Loading…
Medpace Holdings, Inc. is projected to rise to $550.37 by 2027, a +29% move from its current price of $428.00. MEDP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $420.84 | $427.90 | $435.08 | -0.02% |
| May 30 | $417.85 | $427.80 | $437.98 | -0.05% |
| May 31 | $415.55 | $427.70 | $440.20 | -0.07% |
| Jun 1 | $413.61 | $427.60 | $442.06 | -0.09% |
| Jun 2 | $411.89 | $427.50 | $443.70 | -0.12% |
| Jun 3 | $410.33 | $427.40 | $445.17 | -0.14% |
| Jun 4 | $408.90 | $427.30 | $446.52 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $408.90 | $427.30 | $446.52 | -0.16% |
| Week 2 | $400.85 | $426.59 | $453.99 | -0.33% |
| Week 3 | $394.64 | $425.89 | $459.62 | -0.49% |
| Week 4 | $389.37 | $425.19 | $464.31 | -0.66% |
| Week 5 | $384.71 | $424.49 | $468.39 | -0.82% |
| Week 6 | $380.49 | $423.80 | $472.03 | -0.98% |
| Week 7 | $376.60 | $423.10 | $475.34 | -1.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc.
was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings, Inc. (MEDP) is a Healthcare stock currently priced at $432.80 per share, with a market capitalization of $12.36B. It is ranked 797 by market cap. The current technical picture shows a neutral stance with RSI(14) at 50, and moving averages at SMA50 of $456.76 and SMA200 of $512.98.
Support sits at $393.42 while resistance stands at $528.44. The 30-day price range spans from $385.37 to $486.07, and annualized volatility is 30%. The forecast path projects a bullish trajectory beyond 2026, with the 2026 price range and the long-run averages rising to multi-year highs.
A major floor 26.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.1% below — buyers have tended to step in here.
The nearest ceiling, 23.5% above — a clean break opens room to run.
A major ceiling 45.0% above — clearing it would confirm fresh momentum.
Key MEDP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MEDP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $428.38 | Sell | $427.68 | Buy |
| MA 10 | $424.07 | Buy | $426.29 | Buy |
| MA 20 | $422.72 | Buy | $430.59 | Sell |
| MA 50 | $455.83 | Sell | $450.72 | Sell |
| MA 100 | $489.58 | Sell | $473.04 | Sell |
| MA 200 | $512.95 | Sell | $473.91 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.62 | Neutral |
| Stoch RSI (14) | 75.63 | Neutral |
| CCI (20) | 71.68 | Neutral |
| Williams %R (14) | -27.38 | Info |
| MACD (12,26,9) | 3.37 | Buy |
| ROC (12) | 0.94 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 72.62 | Neutral |
| TRIX (15) | -0.40 | Sell |
| Awesome (5,34) | -19.04 | Sell |
| Ultimate (7,14,28) | 63.24 | Neutral |
| Momentum (10) | 8.25 | Buy |
| Aroon Osc (25) | -8.00 | Sell |
| Hull MA (9) | 432.88 | Sell |
| ADX (14) | 17.64 | Neutral |
| ATR (14) | 6.50 | Info |
In the near term, the sentiment is NEUTRAL and the RSI sits at 50. The SMA picture shows the 50-day moving average at $456.76 and the 200-day moving average at $512.98, indicating a delicate balance between near-term momentum and longer-term trend. The stock trades within the 30-day range of $385.37 to $486.07, with a nearby support level at $393.42 and a resistance level at $528.44.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $393.42 | $428.00 | $569.14 | 0% | Neutral | |
| $449.61 | $550.37 | $705.19 | +29% | Bullish | |
| $484.66 | $604.09 | $794.25 | +41% | Bullish | |
| $513.96 | $650.32 | $872.81 | +52% | Bullish | |
| $544.47 | $698.11 | $953.53 | +63% | Bullish | |
| $546.25 | $708.84 | $983.28 | +66% | Bullish | |
| $596.20 | $782.33 | $1,100.48 | +83% | Bullish | |
| $691.32 | $916.63 | $1,305.92 | +114% | Bullish | |
| $765.49 | $1,025.00 | $1,477.60 | +139% | Bullish | |
| $826.38 | $1,116.95 | $1,627.93 | +161% | Bullish | |
| $1,109.18 | $1,563.37 | $2,387.13 | +265% | Bullish | |
| $1,797.07 | $2,716.12 | $4,444.31 | +535% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $393.42 | $428.00 | $499.74 | +0.00% |
| June 2026 | $357.70 | $417.28 | $496.22 | -2.51% |
| July 2026 | $357.05 | $418.92 | $502.89 | +0.39% |
| August 2026 | $365.88 | $431.22 | $521.41 | +2.93% |
| September 2026 | $365.54 | $432.41 | $525.96 | +0.28% |
| October 2026 | $364.49 | $432.64 | $529.08 | +0.05% |
| November 2026 | $376.43 | $448.16 | $550.64 | +3.59% |
| December 2026 | $386.25 | $461.16 | $569.14 | +2.90% |
Click any year to see its month-by-month MEDP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MEDP to range from $393.42 to $569.14 through 2026. The $428.00 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MEDP price prediction for 2027 points to an average of $550.37 (low $449.61, high $705.19) — a potential gain of +29% on today's $428.00. Momentum favours further upside here.
In 2028, MEDP is projected to trade between $484.66 and $794.25, averaging $604.09 — a potential gain of +41% from today's $428.00. That is up +10% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Medpace Holdings, Inc.'s 2029 outlook centres on $650.32, within a $513.96 to $872.81 range. That is up +8% on the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, MEDP could reach as high as $953.53, with a base case around $698.11 and support toward $544.47 — roughly +63% from $428.00. Buyers look set to stay in control over this stretch.
Expect MEDP to range from $546.25 to $983.28 through 2031. The $708.84 average target implies a +66% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The MEDP price prediction for 2032 points to an average of $782.33 (low $596.20, high $1,100.48) — a potential gain of +83% on today's $428.00. Buyers look set to stay in control over this stretch.
In 2033, MEDP is projected to trade between $691.32 and $1,305.92, averaging $916.63 — a potential gain of +114% from today's $428.00. That is up +17% on the projected 2032 average. Momentum favours further upside here.
Medpace Holdings, Inc.'s 2034 outlook centres on $1,025.00, within a $765.49 to $1,477.60 range. That is up +12% on the projected 2033 average. That marks a +139% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MEDP could reach as high as $1,627.93, with a base case around $1,116.95 and support toward $826.38 — roughly +161% from $428.00. Momentum favours further upside here.
Expect MEDP to range from $1,109.18 to $2,387.13 through 2040. The $1,563.37 average target implies a +265% move from current prices. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MEDP price prediction for 2050 points to an average of $2,716.12 (low $1,797.07, high $4,444.31) — a potential gain of +535% on today's $428.00. Momentum favours further upside here.
Investing $1,000 in MEDP today (≈ 2.336449 MEDP) could be worth
$6,346.08
+$5,346.08 (+535%) by 2050 · US Dollar
Based on the average projected MEDP price of $2,716.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MEDPwould be worth at today's price.
$1,000 invested in MEDP on May 27, 2025 (≈ 3.349074 MEDP) would be worth
$1,433.4
+$433.4 (+43.3%) today · 1.43× · US Dollar
Based on a MEDP entry price of $298.59 vs. today's $428.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $421.87 | $1,014.53 | +1.5% |
| 1 month ago | $421.37 | $1,015.73 | +1.6% |
| 3 months ago | $447.09 | $957.3 | -4.3% |
| 6 months ago | $592.46 | $722.41 | -27.8% |
| 1 year ago | $298.59 | $1,433.4 | +43.3% |
| All time (5.0y) ago | $168.52 | $2,539.76 | +154.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MEDP forecast.
Our base-case forecast reaches $860.00 around 2033.
Implied market cap at $860.00: $24.56B
The multi-year forecast shows a bullish trend beginning later in the forecast horizon. The 2026 forecast starts at a min of $393.42, an avg of $432.80, and a max of $578.35 with 0% ROI and a NEUTRAL sentiment. From 2027 onward, the averages rise with a bullish sentiment, reaching $559.15 in 2027, $714.92 in 2030 (ROI 65.2%), $732.22 in 2031, and $805.79 in 2032 (ROI 86.2%).
By 2033 the avg is $950.98 (ROI 119.7%), and by 2034 it is $1,066.07 (ROI 146.3%), continuing upward to $2,836.09 avg in 2050 (ROI 555.3%). The 2040 forecast shows an avg of $1,638.04 (ROI 278.5%) and a 2050 avg of $2,836.09 (ROI 555.3%). These figures imply a strong long-term bullish trajectory, but they are not guarantees and could be influenced by market conditions and company-specific factors.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $714.92, with a minimum of $557.48 and a maximum of $976.73; the forecast shows a 65.2% ROI and a BULLISH sentiment.
The forecast trajectory turns bullish from 2027 onward, with rising average prices (e.g., $559.15 in 2027 and $714.92 in 2030) and positive ROIs (up to 65.2% by 2030 and higher thereafter). The 2026 baseline is $432.80 avg with neutral sentiment, but the longer horizon indicates upside potential; however, these are estimates, not guarantees.
Yes. The forecast max prices exceed $1,000 in multiple years: $1,015.92 in 2031, $1,133.69 in 2032, and $1,355.10 in 2033, with earlier maxs around $976.73 in 2030.
The 2040 forecast shows an average price of $1,638.04 with a 278.5% ROI, and the 2050 forecast shows an average price of $2,836.09 with a 555.3% ROI, both indicating a strong bullish trajectory over the long term.
The 30-day range is $385.37 to $486.07. RSI(14) is 50, with SMA50 at $456.76 and SMA200 at $512.98. The current near-term support is $393.42 and resistance is $528.44.
Medpace Holdings, Inc. Community Discussion
0Share your Medpace Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.